OAM
OM icon

Oppenheimer Asset Management’s Outset Medical OM Stock Holding History

Oppenheimer Asset Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-647
Closed -$441K – 1193
2022
Q1 		$441K Buy
647
+109
+20% +$65.6K 0.01% 944
2021
Q4 		$372K Buy
+538
New +$398K ﹤0.01% 1028

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Oppenheimer Asset Management's OM Position: Q2 2022 in Review

Oppenheimer Asset Management sold out of Outset Medical (OM) in Q2 2022, closing a stake of 647 shares — an estimated $441K sold.

Oppenheimer Asset Management first reported a position in OM in Q4 2021 and held it in 2 quarters. The position peaked at $441K in Q1 2022. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • Oppenheimer Asset Management reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 647 Outset Medical shares in Q2 2022, an estimated $441K.
  • Oppenheimer Asset Management first reported a position in Outset Medical in Q4 2021 and held it in 2 quarters.
  • Oppenheimer Asset Management's Outset Medical position peaked at $441K in Q1 2022.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.